Breastfeeding during the COVID-19 pandemic: what do we know so far?
ABSTRACT Objective This study aimed to conduct a literature review on safety in breastfeeding in mothers with COVID-19. An integrative review of national and international literature was carried out. Methods The search took place in the SciELO, LILACS and MEDLINE® databases. Results A total of 25 scientific articles that specifically addressed the theme of breastfeeding and its risk and protective factors for infection by SARS-CoV-2 were selected. According to the studies analyzed, although the presence of viral RNA had already been detected by reverse transcriptase polymerase chain reaction in breast milk samples, there are still no proven cases of vertical transmission via human milk. Conclusion Breastfeeding appears to be safe if practiced according to precaution measures recommended by the World Health Organization. In addition, there is evidence of a potential for immunological protection by transfer of antibodies against SARS-CoV-2 in breast milk. Breastfeeding should continue to be promoted even in cases of mothers with clinical suspicion or confirmation of COVID-19, as well as the provision of expressed breast milk in cases where there is no possibility of direct breastfeeding..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Einstein (São Paulo) - 20(2022) |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Taison Regis Penariol Natarelli [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Betacoronavirus |
|---|
| doi: |
10.31744/einstein_journal/2022rw6609 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ036515388 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ036515388 | ||
| 003 | DE-627 | ||
| 005 | 20230307231726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.31744/einstein_journal/2022rw6609 |2 doi | |
| 035 | |a (DE-627)DOAJ036515388 | ||
| 035 | |a (DE-599)DOAJ492e238a1124435cb04f15bae4874b0c | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 100 | 0 | |a Taison Regis Penariol Natarelli |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Breastfeeding during the COVID-19 pandemic: what do we know so far? |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Objective This study aimed to conduct a literature review on safety in breastfeeding in mothers with COVID-19. An integrative review of national and international literature was carried out. Methods The search took place in the SciELO, LILACS and MEDLINE® databases. Results A total of 25 scientific articles that specifically addressed the theme of breastfeeding and its risk and protective factors for infection by SARS-CoV-2 were selected. According to the studies analyzed, although the presence of viral RNA had already been detected by reverse transcriptase polymerase chain reaction in breast milk samples, there are still no proven cases of vertical transmission via human milk. Conclusion Breastfeeding appears to be safe if practiced according to precaution measures recommended by the World Health Organization. In addition, there is evidence of a potential for immunological protection by transfer of antibodies against SARS-CoV-2 in breast milk. Breastfeeding should continue to be promoted even in cases of mothers with clinical suspicion or confirmation of COVID-19, as well as the provision of expressed breast milk in cases where there is no possibility of direct breastfeeding. | ||
| 650 | 4 | |a Breast feeding | |
| 650 | 4 | |a Lactation | |
| 650 | 4 | |a Milk, human | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus infections | |
| 650 | 4 | |a Betacoronavirus | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Infant, newborn | |
| 650 | 4 | |a Child health | |
| 650 | 4 | |a Protective factors | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Heloisa Gasparini Marigheti Brassarola |e verfasserin |4 aut | |
| 700 | 0 | |a Luciana Mara Monti Fonseca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Einstein (São Paulo) |d Instituto Israelita de Ensino e Pesquisa Albert Einstein, 2017 |g 20(2022) |w (DE-627)DOAJ000103438 |x 23176385 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |
| 856 | 4 | 0 | |u https://doi.org/10.31744/einstein_journal/2022rw6609 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/492e238a1124435cb04f15bae4874b0c |z kostenfrei |
| 856 | 4 | 0 | |u http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082022000100404&tlng=en |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2317-6385 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 | ||